Beckman Coulter, IncellDx Ink Distribution Pact for HPV, Cancer Research in Asian Countries | GenomeWeb

NEW YORK (GenomeWeb) – Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement focusing on human papillomavirus and cancer research in China, Hong Kong, and Taiwan.

Under the agreement, IncellDx's investigational molecular assay used to quantify HPV E6/E7 mRNA in single cells has been optimized to run on Beckman Coulter's CytoFlex flow cytometry system. This platform is able to integrate E6/E7 mRNA overexpression with measurements of cell cycle and cell proliferation, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.